H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
21%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Get your full text copy in PDF

Attempt to evaluate the effects of therapeutic secretin administration to patients with childhood autism

Barbara Kamińska, Maria Korzon, Ewa Kozielska, Mariusz Czaja

Med Sci Monit 2003; 9(4): 41-43

ID: 428635


The aim of the study was to attempt evaluation of the effects of secretin on psychomotor development of patients with childhood autism. The studied group comprised 18 children and adolescents aged 4 –18.Secretin was administered i.v.at 0.5 to 2.0 CU/kg doses, ini-tially at 2, and then at 6-week intervals. The effects of the therapy were assessed on the basis of a questionnaire containing 73 detailed questions concerning the current psychomotor condition of the patient. The patients ’parents answered identical questionnaires before and after the treatment. On the basis of the collected material it can be concluded that secretin did not cause behavioral improvement in most autistic patients. On the other hand, it was observed that the secretin preparation used did not cause any side effects.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree